Presentations
Read the latest Presentations from Asarina Pharma, containing full details of Sepranolone, our first-in-class therapy for PMDD, our science, pipeline and business intelligence.
Meet our CEO Peter Nordkild, COO Karin Ekberg and CBO Otto Skolling as they present to investors in Stockholm, Gothenburg and online.
REDEYE: CEO Peter Nordkild presents at Redeye Growth Day June 2 2021
REDEYE: Asarina Pharma: CEO Peter Nordkild presents at Investor Forum Online Feb 25th
REDEYE: Asarina Pharma: Interview with CEO Peter Nordkild
REDEYE: Asarina Pharma: CEO Peter Norkild presents at Redeye Life Science Day 2020
REDEYE: Asarina Pharma: CEO Peter Nordkild presents at Neurology Seminar 2020
Archive
Press Kit
Access a range of resources on the Asarina Pharma team and offering.
The team
Management team
Scientific Advisory board